Researchers at MBZUAI have developed a new machine learning method called survival rank-n-contrast (SurvRNC) to improve survival models for cancer prognoses. The method is designed to predict survival times for head and neck cancer patients using multimodal data while accounting for censored data (missing values). Numan Saeed presented the team’s work at the 27th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI). Why it matters: Accurate prognoses can significantly improve patient outcomes, and this research contributes to advancements in machine learning techniques for handling complex and incomplete medical data.
MBZUAI researchers developed Human-in-the-Loop for Prognosis (HuLP), a new AI system designed to help physicians assess cancer progression by providing information about its predictions and allowing user intervention. The system aims to foster collaboration between physicians and AI, rather than replacing doctors. It was presented at the 27th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI). Why it matters: This research highlights the potential of AI to augment physician expertise in critical areas like cancer prognosis, improving patient care and treatment decisions.
Søren Brunak presented deep learning approaches for analyzing disease trajectories using data from 7-10 million patients in Denmark and the USA. The models predict future outcomes like mortality and specific diagnoses, such as pancreatic cancer, using 15-40 years of patient data. Disease trajectories and explainable AI can generate hypotheses for molecular-level investigations into causal aspects of disease progression. Why it matters: This research demonstrates the potential of large-scale patient data and AI to improve disease prediction and generate hypotheses for further investigation into disease mechanisms relevant to regional healthcare systems.
A senior lecturer at the University of New South Wales discussed the use of AI to improve early prognosis and personalized treatment plans for neurodegenerative diseases, cardiovascular imaging and multiomics. The lecture highlighted the potential of AI algorithms to detect subtle changes at early stages through advanced multiomics techniques and medical imaging analysis. The speaker has expertise in analyzing medical images and has collaborated with medical professionals to develop AI tools for diagnosis of cancer, neurodegenerative disease, and heart disease. Why it matters: AI-driven prognosis and treatment planning promises earlier intervention and improved outcomes for challenging diseases in the region.
Petar Stojanov from the Broad Institute of MIT and Harvard will give a talk on cancer data analysis, covering the fundamentals of cancer, the nature of large-scale data collected, and main analysis objectives. The talk will also address open questions in cancer data analysis and how machine learning and generative modeling can help. Stojanov's research focuses on applying machine learning to genomic analysis of cancer mutation and single-cell RNA sequencing data. Why it matters: Applying AI and machine learning to cancer research can lead to a better understanding of the disease and development of new therapies.